Clarimedix, a clinical-stage therapeutic device company founded in 2006 and based in Aurora, Colorado, develops a portfolio of safe and effective products for treating diseases caused by vascular dysfunction. Their light-based LED patch triggers the production of nitric oxide, increasing blood flow, reducing vasoconstriction and inflammation, and improving oxygen delivery. The company offers products for the treatment of Cerebral Vasospasm, Raynaud’s Syndrome, and Alzheimer’s disease. Clarimedix's technology provides a drug-like response without the side effects associated with conventional nitric oxide therapies.